Compare KOPN & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOPN | STIM |
|---|---|---|
| Founded | 1984 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 856.9M | 120.4M |
| IPO Year | 2025 | 2018 |
| Metric | KOPN | STIM |
|---|---|---|
| Price | $3.09 | $1.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $8.57 | $6.00 |
| AVG Volume (30 Days) | ★ 3.2M | 2.3M |
| Earning Date | 11-10-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 103.03 | 57.25 |
| EPS | ★ N/A | N/A |
| Revenue | $1,530,311.00 | ★ $52,776,000.00 |
| Revenue This Year | $56.19 | $8.63 |
| Revenue Next Year | $31.90 | $9.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 46.53 | N/A |
| 52 Week Low | $1.81 | $0.80 |
| 52 Week High | $6.61 | $3.44 |
| Indicator | KOPN | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 41.23 | 29.12 |
| Support Level | $2.65 | $1.13 |
| Resistance Level | $4.39 | $1.61 |
| Average True Range (ATR) | 0.31 | 0.28 |
| MACD | 0.01 | -0.10 |
| Stochastic Oscillator | 28.80 | 4.59 |
Kopin Corp is a developer and provider of inventive display, and application-specific optical solutions sold as critical components and subassemblies for defense, enterprise, professional and consumer products. Its portfolio includes micro displays, display modules, eyepiece assemblies, image projection modules, and vehicle mounted and head-mounted display systems that incorporate ultra-small high-resolution Active Matrix Liquid Crystal displays (AMLCD), Ferroelectric Liquid Crystal on Silicon (FLCoS) displays, MicroLED displays (uLED) and Organic Light Emitting Diode (OLED) displays, a variety of optics, and low-power ASICs. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.